$ENZN ENZON PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ENZON PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ENZON PHARMACEUTICALS, INC. for free.

CIK Number: 0000727510
IRS Number: 222372868
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ENZN
Company Address: 20 COMMERCE DRIVE, SUITE 135 CRANFORD 07016
Former name: ENZON INC, date of change: 1992-07-03
Former name: ENZON PHARMACEUTICAL INC, date of change: 2002-12-10
Former name: ENZON PHARMACEUTICALS INC, date of change: 2002-12-11

Enzon Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in the provision of licensing arrangements. It also involve in selling marketed drug products namely: PegIntron, Sylatron, Macugen, and CIMZIA. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

Market Capitalization: $15.28M
Prev close: $0.35
Average Daily Volume: 226,571
Days Low: $0.35
Year Low: $0.31
Year High: $0.56

ENZON PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 29 2016ENZNENZON PHARMACEUTIC ...ICAHN CARL C10% OwnerOption ExerciseH1.09110
Nov 29 2016ENZNENZON PHARMACEUTIC ...ICAHN CARL C10% OwnerBuyP0.41694,023281,0796,598,8865.9 M to 6.6 M (+11.75 %)
Sep 19 2013ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS1.6921,11935,62642,18963.3 K to 42.2 K (-33.36 %)
Sep 19 2013ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS1.7434,80760,45663,30898.1 K to 63.3 K (-35.48 %)
Jan 25 2013ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...GrantA0.004,686078,01973.3 K to 78 K (+6.39 %)
Jan 25 2013ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...GrantA0.003,748079,24675.5 K to 79.2 K (+4.96 %)
Jan 25 2013ENZNENZON PHARMACEUTIC ...Conover CharlesSVP, R&D Program Ma ...GrantA0.002,343074,79372.5 K to 74.8 K (+3.23 %)
Jan 04 2013ENZNENZON PHARMACEUTIC ...Young Richard ADirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorOption ExerciseA4.5435,226159,92635,226
Jan 04 2013ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorOption ExerciseA4.5440,258182,77140,258
Nov 08 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEInterim PEO and Int ...Option ExerciseA6.1873,500454,23073,500
Nov 08 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEInterim PEO and Int ...GrantA0.0024,500043,23718.7 K to 43.2 K (+130.76 %)

View all ENZON PHARMACEUTICALS, INC. insider transactions.